. Author manuscript; available in PMC: 2022 Jan 1.

Published in final edited form as: Neuroendocrinology. 2020 Feb 20;111(1-2):87–98. doi: 10.1159/000506638

Table 3.

Associations between fasting oxytocin and vasopressin levels and BMD and HSA characteristics in CDI and APD participants.

	Oxytocin				Vasopressin
	CDI participants (N=17)		APD participants (N=20)		CDI participants (N=17)		APD participants (N=20)
	R	P	R	P	R	P	R	P
Bone mineral density
PA lumbar spine BMD Z-score	0.556	0.020^*	0.181	0.458	−0.153	0.555	0.168	0.478
Total hip BMD Z-score	0.558	0.020^*	−0.102	0.668	0.193	0.457	0.037	0.874
Femoral neck BMD Z-score	0.693	0.002^*	−0.118	0.618	−0.233	0.368	−0.074	0.758
Distal 1/3 radius BMD Z-score	0.540	0.025	0.112	0.638	−0.031	0.905	−0.377	0.101
Subtotal body BMD Z-score	0.745	0.001^*	−0.040	0.866	−0.189	0.468	0.113	0.634
Hip structural analysis variables
NN cortical thickness (cm)	0.547	0.023	−0.177	0.455	−0.174	0.503	−0.169	0.474
NN section modulus (cm³)	0.523	0.031	0.088	0.712	−0.458	0.068	−0.199	0.400
NN buckling ratio	−0.448	0.071	0.078	0.744	−0.159	0.540	0.197	0.405
IT cortical thickness (cm)	0.666	0.004^*	−0.187	0.429	−0.017	0.947	0.117	0.623
IT section modulus (cm³)	0.566	0.018^*	−0.179	0.449	−0.155	0.551	0.167	0.480
IT buckling ratio	−0.637	0.006^*	0.128	0.589	−0.196	0.451	−0.051	0.830
FS cortical thickness (cm)	0.510	0.036	−0.015	0.951	0.131	0.615	0.220	0.351
FS section modulus (cm³)	0.373	0.140	−0.139	0.560	−0.242	0.286	0.145	0.541
FS buckling ratio	−0.400	0.111	0.029	0.904	−0.339	0.182	−0.228	0.333

R, Pearson coefficient; P, P value

significant after Holm-Bonferroni correction.

Abbreviations: BMD, bone mineral density; CDI, central diabetes insipidus; PA, posteroanterior; NN, narrow neck; IT, intertrochanteric region; FS, femoral shaft.